Emerging research also suggests they could benefit cardiovascular health , vascular diseases , and even addictive behaviors
Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease
GLP-1 Cost Management, Coverage, and Demand Skyrocketing costs are one challenge
Our mission is to help you embrace a healthier lifestyle through science and empathy
The Bottom Line: Should You Prescribe Weight Loss Medications
Mental health concerns, including anxiety and depression, especially with semaglutide, were also notable but occurred less often than GI symptoms, with Wegovy showing the highest depression mention rate